Xience Prime

Earlier-generation everolimus-eluting cobalt-chromium coronary stent, FDA approval announced in 2011, marketed as having one of the thinnest drug-eluting-stent struts of its time. Superseded by later Xience generations.

Stent Material

Cobalt-chromium

Drug

Everolimus

FDA Approval

2011